WFA Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$26.8K Hold
233
0.01% 131
2025
Q2
$24.8K Hold
233
0.01% 135
2025
Q1
$22.5K Hold
233
0.01% 150
2024
Q4
$22.7K Hold
233
0.01% 153
2024
Q3
$26.8K Hold
233
0.01% 132
2024
Q2
$24.8K Hold
233
0.01% 136
2024
Q1
$22.5K Hold
233
0.01% 151
2023
Q4
$23.5K Hold
233
0.01% 136
2023
Q3
$23.7K Hold
233
0.01% 138
2023
Q2
$23.5K Hold
233
0.01% 144
2023
Q1
$21.4K Hold
233
0.01% 140
2022
Q4
$21.1K Hold
233
0.01% 122
2022
Q3
$17.7K Hold
233
0.01% 130
2022
Q2
$19.7K Hold
233
0.01% 126
2022
Q1
$20.4K Hold
233
0.01% 128
2021
Q4
$20.4K Buy
+233
New +$19.3K 0.01% 125

Other funds holding NVS

WFA Asset Management's NVS Position: Q3 2025 in Review

WFA Asset Management held its Novartis (NVS) position steady in Q3 2025 at 233 shares worth $26.8K. The position accounts for 0.01% of the portfolio, ranked #131.

WFA Asset Management first reported a position in NVS in Q4 2021 and has held it in 16 quarters since. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • WFA Asset Management held 233 shares of Novartis worth $26.8K as of Q3 2025.
  • WFA Asset Management left its Novartis share count unchanged in Q3 2025.
  • Novartis made up 0.01% of WFA Asset Management's portfolio in Q3 2025, its #131 holding.
  • WFA Asset Management first reported a position in Novartis in Q4 2021 and has held it in 16 quarters since.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.